Intractable Rheumatoid Arthritis: Treatment With Combined Cyclophosphamide, Azathioprine, and Hydroxychloroquine

JAMA: The Journal of the American Medical Association

Volumn 248, Issue 14, 1982, Pages 1718-1723

  Mccarty, Daniel J ^a   Carrera, Guillermo F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GOLD SALT; HYDROXYCHLOROQUINE; PREDNISONE;

ADVERSE DRUG REACTION; AMENORRHEA; BACTERIAL INFECTION; BLADDER; CYSTITIS; DIGESTIVE SYSTEM; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HEADACHE; HERPES ZOSTER; JOINT; ORAL DRUG ADMINISTRATION; PRURITUS; RHEUMATOID ARTHRITIS; THERAPY;

ARTHRITIS, RHEUMATOID; AZATHIOPRINE; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HAND; HUMAN; HYDROXYCHLOROQUINE; MALE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0019987456     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1982.03330140028027     Document Type: Article

References (27)

1. Lightfoot RW Jr: Treatment of rheumatoid arthritis, in McCarty DJ (ed): Arthritis and Allied Conditions, ed 9. Philadelphia, Lea & Febiger, 1979, pp 513-518.
2. Fosdick WM, Parsons JL, Hill DF: Long-term cyclophosphamide therapy in rheumatoid arthritis. Arthritis Rheum 1968;11:151-161.
3. A controlled trial of cyclophosphamide in rheumatoid arthritis, Cooperating Clinics Committee of the American Rheumatism Association. N Engl J Med 1970;283:883-889.
4. Lidsky MD, Sharp JT, Billings S: Double blind study of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum 1973;16:149-153.
5. A controlled trial of high and low doses of cyclophosphamide in 82 patients with rheumatoid arthritis, Cooperating Clinics Committee of the American Rheumatism Association, abstracted. Arthritis Rheum 1972;15:434.
6. Townes AS, Sowa JM, Shulman LE: Controlled trial of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum 1976;19:563-573.
7. Smyth CJ, Bartholomew BA, Mills DM, et al.: Cyclophosphamide therapy for rheumatoid arthritis. Arch Intern Med 1975;135:789-793.
8. Williams HJ, Reading JC, Ward JR, et al.: Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis. Arthritis Rheum 1980;23:521-527.
9. Currey HLF, Harris J, Mason RM, et al.: Comparison of azathioprine, cyclophosphamide and gold in the treatment of rheumatoid arthritis. Br Med J 1974;3:763-766.
10. Jones JV, Clough JD, Klinenberg JR, et al.: The role of therapeutic plasmapheresis in the rheumatic diseases. J Lab Clin Med 1981;97:589.
11. Kotzin BL, Strober S, Engleman EG, et al.: Treatment of intractable rheumatoid arthritis with total lymphoid irradiation (TLI). N Engl J Med 1981;305:969-975.
12. Trentham DE, Belli JA, Anderson RJ, et al.: Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med 1981; 305:976-981.
13. Ropes MW, Bennett GA, Cobb S: Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;9:175-176.
14. McCarty DJ: Clinical assessment of arthritis, in McCarty DJ (ed): Arthritis and Allied Conditions, ed 9. Philadelphia, Lea & Febiger, 1979, pp 51-69.
15. Genant H: Radiology of rheumatic diseases, in McCarty DJ (ed): Arthritis and Allied Conditions, ed 9. Philadelphia, Lea & Febiger, 1979, pp 70-130.
16. Snedecor GW: Statistical Methods. Ames, Iowa, Iowa State College Press, 1956, pp 115-117.
17. Mason M, Currey HLF, Barnes CG, et al.: Azathioprine in rheumatoid arthritis. Br Med J 1969;1:420-422.
18. Urowitz MB, Gordon DA, Smythe HA, et al.: Azathioprine in rheumatoid arthritis: A double-blind crossover study. Arthritis Rheum 1973;16:411-418.
19. Urowitz MB, Hunter T, Bookman AAM: Azathioprine in rheumatoid arthritis: A double-blind study comparing full dose to half dose. J Rheumatol 1974;1:274-281.
20. Hunter T, Urowitz MB, Gordon DA, et al.: Azathioprine in rheumatoid arthritis: A long-term follow-up study. Arthritis Rheum 1975; 18:15-20.
21. Goebel KM, Janzen R, Joseph K, et al.: Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis. Eur J Clin Pharmacol 1976;9:405-410.
22. Cade R, Stein G, Pickering M, et al.: Low dose, long-term treatment of rheumatoid arthritis with azathioprine. South Med J 1976;69:388-392.
23. Dwosh IL, Stein HB, Urowitz MB, et al.: Azathioprine in early rheumatoid arthritis: Comparison with gold and chloroquine. Arthritis Rheum 1977;20:685-692.
24. Woodland J, Chaput DeSaintonge DM, Evans SJW, et al.: Azathioprine in rheumatoid arthritis: Double-blind study of full versus half doses versus placebo. Ann Rheum Dis 1981; 40:355-359.
25. Pinals RS: Azathioprine in the treatment of chronic polyarthritis: Long-term results and adverse effects in 25 patients. J Rheumatol 1976;3:140-144.
26. Zvaifler NJ: Gold and anti-malarial therapy, in McCarty DJ (ed): Arthritis and Allied Conditions, ed 9. Philadelphia, Lea & Febiger, 1979, pp 364-367.
27. McCarty DJ: Treating intractable rheumatoid arthritis. N Engl J Med 1981;305:1009.